Search clinical trials for: HER-2/neu peptide vaccine
Total 1404 results
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | HER2/Neu Positive | HLA-A2 Positive Cells Present | Stage IV Ovarian CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of WashingtonCompletedBreast Cancer | Ovarian Cancer | Lung CancerUnited States
-
University of WashingtonCompletedBreast Cancer | Ovarian Cancer | Lung CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
University of PennsylvaniaAbramson Cancer Center of the University of PennsylvaniaNo longer availableMetastatic CancerUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)CompletedEvaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer (Breast 37)Breast NeoplasmsUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Ovarian CancerUnited States
-
Robert WesolowskiCompletedBreast Cancer | Ovarian Cancer | Malignant Solid Tumour | GIST | Malignant Tumor of ColonUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Craig L Slingluff, JrTerminatedBreast CancerUnited States
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research Alliance; Ontario Cancer Research NetworkCompletedMetastatic Breast Cancer | Recurrent Breast CancerCanada
-
Craig L Slingluff, JrNational Cancer Institute (NCI)TerminatedColorectal CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Gitte KronborgRigshospitalet, Denmark; Hvidovre University Hospital; Statens Serum Institut; Ministry...Completed
-
National Liver Institute, EgyptUnknownVaccine Overdose of Undetermined IntentEgypt
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Hodgkin Lymphoma | Myelofibrosis | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Myelodysplastic/Myeloproliferative Neoplasm | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in Remission | Cytomegalovirus... and other conditionsUnited States
-
International Centre for Diarrhoeal Disease Research...Completed
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin MelanomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingHematopoietic Cell Transplant Recipient | Cytomegaloviral InfectionUnited States
-
NantBioScience, Inc.Unknown
-
University of WashingtonNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | HER2/Neu PositiveUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteAbramson Cancer Center at Penn MedicineCompletedBreast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedNonneoplastic ConditionUnited States
-
United BiomedicalCompleted
-
M.D. Anderson Cancer CenterThe Vaccine CompanyTerminated
-
University of Alabama at BirminghamNational Cancer Institute (NCI)WithdrawnBreast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific
-
University of Maryland Greenebaum Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Janssen Pharmaceutical K.K.CompletedHeart Failure, CongestiveJapan
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Enimmune CorporationCompleted
-
University of WashingtonNational Cancer Institute (NCI)Completed
-
COL George Peoples, MD, FACSCompletedOvarian Cancer | Endometrial Cancer | Peritoneal Cancer | Fallopian CancerUnited States
-
Michael Morse, MDImmunotopeCompletedEpithelial Ovarian, Tubal or Peritoneal CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast Ductal Carcinoma In SituUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Diavax BiosciencesActive, not recruitingHodgkin Lymphoma | Myelofibrosis | Lymphoblastic Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Lymphadenopathy | Myeloproliferative Neoplasm | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Myeloid Leukemia in Remission | Accelerated Phase... and other conditionsUnited States
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML) | Chronic Myeloid Leukemia (CML)United States
-
Sanofi Pasteur, a Sanofi CompanyCompletedHepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type B InfectionMexico
-
George E. PeoplesGenentech, Inc.; Sellas Life Sciences GroupCompleted
-
HenogenCompleted
-
University Hospital TuebingenNot yet recruitingAcute Myeloid Leukemia, Adult
-
COL George Peoples, MD, FACSM.D. Anderson Cancer CenterCompletedBreast Cancer | Ovarian CancerUnited States